Receptor Tyrosine Kinases as Therapeutic Targets the Model of the MET Oncogene
Journal:
Current Drug Targets
Volume:
2
Page:
41-55
Author(s):
Paola Longati, Paolo M. Comoglio and Alberto Bardelli
SUBJECT INDEX TO VOLUME 1
Journal:
Current Drug Targets
Volume:
2
Page:
111-115
Author(s):
Publishers Science Bentham
Gene Therapy for Lung Diseases Development in the Vector Biology and Novel Concepts for Gene Therapy Applications
Journal:
Current Molecular Medicine
Volume:
1
Page:
67-79
Author(s):
M. Suzuki, T. Matsuse and Y. Isigatsubo
Microdissection and the Study of Cancer Pathways
Journal:
Current Molecular Medicine
Volume:
1
Page:
153-162
Author(s):
Anirban Maitra, Ignacio I. Wistuba and Adi F. Gazdar
Proteomics as a Tool in the Pharmaceutical Drug Design Process
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
291-310
Author(s):
M. Yosida, J. A. Loo and R. A. Lepley
Antibody Engineering for Targeted Therapy of Cancer Recombinant Fv-Immunotoxins
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
19-46
Author(s):
Revital Niv, Cyril J. Cohen, Galit Denkberg, Dina Segal and Yoram Reiter
The Mouse In Cancer Research Past, Present, Future
Journal:
Current Genomics
Volume:
2
Page:
1-26
Author(s):
K. Hunter and D. Cozma
SUBJECT INDEX TO VOLUME 1
Journal:
Current Genomics
Volume:
2
Page:
87-89
Author(s):
Publishers Science Bentham
Bestatin as an Experimental Tool in Mammals
Journal:
Current Drug Metabolism
Volume:
2
Page:
67-85
Author(s):
O. A. Scornik and V. Botbol
CMT-3, a Non-antimicrobial Tetracycline (TC), Inhibits MT1-MMP Activity: Relevance to Cancer
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
257-260
Author(s):
M. H. Lee, M. L. Golub, J. Cao, O. Teronen, M. Laitinen, T. Salo, S. Zucker and T. Sorsa